North China Pharmaceutical Company.,Ltd.’s Net Profit Rose 124.9% in First Three Quarters of 2022

North China Pharmaceutical Company.,Ltd. (华北制药股份有限公司) (600812.SH) reported a net profit of 54.7 million yuan in the first three quarters of 2022, up 124.9% year-on-year.

Meanwhile, the company posted 7.9 billion yuan in revenue, down 3.8% year-on-year.

At the end of the reporting period, it had 23.2 billion yuan in total assets and 16.2 billion yuan in total liabilities, with a liability-to-asset ratio of 69.9%.